Autopsy report · NCT01290380
A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies
Cause of deathNo reason given
Life of this trial
- Registered 11 months after it had already started.
- 54 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Solid Tumor Malignancies
- Interventions
- ASA404, DMXAA, DXAA
- Participants
- 54
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.